133 related articles for article (PubMed ID: 36459029)
1. Delayed cervical cancer diagnosis: a systematic review.
Allahqoli L; Dehdari T; Rahmani A; Fallahi A; Gharacheh M; Hajinasab N; Salehiniya H; Alkatout I
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8467-8480. PubMed ID: 36459029
[TBL] [Abstract][Full Text] [Related]
2. Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, Serbia.
Jovanovic V; Mitrovic Jovanovic A; Zivanovic A; Kocic S; Vasiljevic M; Krasic V
Eur J Gynaecol Oncol; 2017; 38(1):69-75. PubMed ID: 29767868
[TBL] [Abstract][Full Text] [Related]
3. Factors related to cervical cancer screening among Asian women.
Salehiniya H; Momenimovahed Z; Allahqoli L; Momenimovahed S; Alkatout I
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):6109-6122. PubMed ID: 34661271
[TBL] [Abstract][Full Text] [Related]
4. Estimates of delays in diagnosis of cervical cancer in Nepal.
Gyenwali D; Khanal G; Paudel R; Amatya A; Pariyar J; Onta SR
BMC Womens Health; 2014 Feb; 14(1):29. PubMed ID: 24533670
[TBL] [Abstract][Full Text] [Related]
5. Has COVID-19 Affected Cancer Screening Programs? A Systematic Review.
Alkatout I; Biebl M; Momenimovahed Z; Giovannucci E; Hadavandsiri F; Salehiniya H; Allahqoli L
Front Oncol; 2021; 11():675038. PubMed ID: 34079764
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Cervical Cancer and Pre-Cancerous Lesions by Artificial Intelligence: A Systematic Review.
Allahqoli L; Laganà AS; Mazidimoradi A; Salehiniya H; Günther V; Chiantera V; Karimi Goghari S; Ghiasvand MM; Rahmani A; Momenimovahed Z; Alkatout I
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428831
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
8. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with delayed diagnosis of cervical cancer in Iran--a survey in Isfahan City.
Behnamfar F; Azadehrah M
Asian Pac J Cancer Prev; 2015; 16(2):635-9. PubMed ID: 25684499
[TBL] [Abstract][Full Text] [Related]
10. Perceptions of cervical cancer care among Ethiopian women and their providers: a qualitative study.
Burrowes S; Holcombe SJ; Leshargie CT; Hernandez A; Ho A; Galivan M; Youb F; Mahmoud E
Reprod Health; 2022 Jan; 19(1):2. PubMed ID: 34983586
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
Sumarmi S; Hsu YY; Cheng YM; Lee SH
Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
[TBL] [Abstract][Full Text] [Related]
12. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
13. Delay in Diagnosis of Cervical Cancer in Afghanistan: A Pilot Cross-Sectional Survey.
Acuti Martellucci C; Delsoz M; Qaderi S; Madadi S; Bhandari D; Ozaki A; Mousavi SH
Front Reprod Health; 2021; 3():783271. PubMed ID: 36303966
[No Abstract] [Full Text] [Related]
14. Barriers and facilitators in cervical cancer screening uptake in Abidjan, Côte d'Ivoire in 2018: a cross-sectional study.
Boni SP; Gnahatin F; Comoé JC; Tchounga B; Ekouevi D; Horo A; Adoubi I; Jaquet A
BMC Cancer; 2021 Aug; 21(1):952. PubMed ID: 34433459
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
[TBL] [Abstract][Full Text] [Related]
16. Jordanian women's attitudes towards cervical cancer screening: has the pattern changed?
Asali F; Abdel-Razeq R; Al-Thunaibat A; Okour A; Abu Mahfouz S; Abu Mahfouz I
J Obstet Gynaecol; 2020 May; 40(4):564-568. PubMed ID: 31478428
[TBL] [Abstract][Full Text] [Related]
17. Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer.
Robinson KM; Christensen KB; Ottesen B; Krasnik A
Eur J Cancer Care (Engl); 2011 Sep; 20(5):653-61. PubMed ID: 21771126
[TBL] [Abstract][Full Text] [Related]
18. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
20. Women's Cancer Care in Iran.
Joulaei H; Zarei N
Cancer Control; 2019; 26(1):1073274819848432. PubMed ID: 31094222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
